Lista de obras - Véronique Quillien - Dominio Público Uruguay

A 4-gene signature associated with clinical outcome in high-grade gliomas

artículo científico publicado en 2011

A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.

artículo científico publicado en 2015

A new mutation in the BRCA1 gene (g.5196-5201del6, 5195-5202ins12), a 6 bp deletion replaced by the duplication of a 12 bp adjacent upstream intronic sequence

artículo científico publicado en 2001

Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients.

artículo científico publicado en 2019

Biodistribution of 111indium-labeled macrophages infused intravenously in patients with renal carcinoma

artículo científico publicado en 2001

Biodistribution of radiolabelled human dendritic cells injected by various routes

artículo científico publicado en 2005

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma

artículo científico publicado en 2017

Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.

artículo científico publicado en 2017

Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation

scientific article published on 01 January 1995

Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma

artículo científico publicado en 1998

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures ⬇️

artículo científico publicado el 26 de octubre de 2012

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide

artículo científico publicado en 2014

DNA methylation in glioblastoma: impact on gene expression and clinical outcome

artículo científico publicado en 2010

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.

artículo científico publicado en 2011

Dual IRE1 RNase functions dictate glioblastoma development.

artículo científico publicado en 2018

Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction.

artículo científico publicado en 2005

Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives.

artículo científico publicado en 2017

Expression of MAGE genes in esophageal squamous-cell carcinoma

scientific article published on 01 January 1997

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.

artículo científico publicado en 2006

First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast Carcinoma

artículo científico publicado en 2018

Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

artículo científico publicado en 2011

Immune genes are associated with human glioblastoma pathology and patient survival.

artículo científico publicado en 2012

Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients

artículo científico publicado en 2006

Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects

artículo científico publicado en 2003

Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.

artículo científico publicado en 2009

Isolation of a new cell population in the glioblastoma microenvironment.

artículo científico publicado en 2011

Mechanisms of immunomodulation in human glioblastoma.

artículo científico publicado en 2011

Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs.

artículo científico publicado en 2009

Overview of cellular immunotherapy for patients with glioblastoma.

artículo científico publicado en 2010

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

artículo científico publicado en 2003

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

scientific article published on 01 January 2002

Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas

artículo científico publicado en 2013

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

artículo científico publicado en 2009

Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study.

artículo científico publicado en 1999

Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells

scientific article published on 01 December 2008

Proteomic analysis of glioblastomas: what is the best brain control sample?

artículo científico publicado en 2013

Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.

artículo científico publicado en 2014

Reprint of: Signaling the Unfolded Protein Response in primary brain cancers

artículo científico publicado en 2016

Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA)

article

Serum anti-p53 antibodies in patients with squamous cell carcinoma of the esophagus.

artículo científico publicado en 1997

Signaling the Unfolded Protein Response in primary brain cancers

artículo científico publicado en 2016

Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.

artículo científico publicado en 2001

[Epigenetic regulation in glioblastomas].

artículo científico publicado en 2009

[Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene]

artículo científico publicado en 1997

[Gene therapy of cerebral glioblastoma by adenovirus vector. Experimental model in the rat]

artículo científico publicado en 1998

[MGMT analysis in gliomas].

artículo científico publicado en 2011

[Protein S100 beta and Melanoma Inhibitory Activity (MIA): a prospective study of their clinical value for the early detection of metastasis in malignant melanoma]

scientific article published on 01 June 2007

[Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].

artículo científico publicado en 2012

[Serum S100B protein and stage of cutaneous melanoma: a prospective study]

scientific article published on 01 January 2000

[Vaccinal cell therapy in melanoma]

artículo científico publicado en 2003

Lista de obras de Véronique Quillien

A 4-gene signature associated with clinical outcome in high-grade gliomas

A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.

A new mutation in the BRCA1 gene (g.5196-5201del6, 5195-5202ins12), a 6 bp deletion replaced by the duplication of a 12 bp adjacent upstream intronic sequence

Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients.

Biodistribution of 111indium-labeled macrophages infused intravenously in patients with renal carcinoma

Biodistribution of radiolabelled human dendritic cells injected by various routes

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma

Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.

Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation

Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures ⬇️

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide

DNA methylation in glioblastoma: impact on gene expression and clinical outcome

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.

Dual IRE1 RNase functions dictate glioblastoma development.

Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction.

Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives.

Expression of MAGE genes in esophageal squamous-cell carcinoma

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.

First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast Carcinoma

Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

Immune genes are associated with human glioblastoma pathology and patient survival.

Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients

Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects

Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.

Isolation of a new cell population in the glioblastoma microenvironment.

Mechanisms of immunomodulation in human glioblastoma.

Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs.

Overview of cellular immunotherapy for patients with glioblastoma.

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study.

Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells

Proteomic analysis of glioblastomas: what is the best brain control sample?

Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.

Reprint of: Signaling the Unfolded Protein Response in primary brain cancers

Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA)

Serum anti-p53 antibodies in patients with squamous cell carcinoma of the esophagus.

Signaling the Unfolded Protein Response in primary brain cancers

Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.

[Epigenetic regulation in glioblastomas].

[Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene]

[Gene therapy of cerebral glioblastoma by adenovirus vector. Experimental model in the rat]

[MGMT analysis in gliomas].

[Protein S100 beta and Melanoma Inhibitory Activity (MIA): a prospective study of their clinical value for the early detection of metastasis in malignant melanoma]

[Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].

[Serum S100B protein and stage of cutaneous melanoma: a prospective study]

[Vaccinal cell therapy in melanoma]